Skip to Content


Public Conference-Vitamin D: Moving Toward Evidence-Based Decision Making for Primary Care

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


A conference to identify issues surrounding evidence-based decision making for vitamin D in primary care will be held December 2-3, 2014, on the main campus of the National Institutes of Health (NIH) in Bethesda, Maryland. It will also be broadcast as a webinar. The conference discussions will serve to highlight research gaps as well as data and methodological needs relevant to reducing uncertainties surrounding vitamin D in primary care practice. All persons are invited to attend, especially clinical educators, those who develop clinical recommendations, health care providers and researchers. Persons wishing to attend are required to register in advance of the conference.


December 2-3, 2014; 8:00 to 5:00 p.m. (Eastern Time) on first day and 8:00 to noon on second day.


National Institutes of Health, William H. Natcher Building; Natcher Conference Center, Building 45. Bethesda, Maryland, 20892.

Start Further Info


Ms. Cindy Rooney, Office of Dietary Supplements, National Institutes of Health, 6100 Executive Boulevard, Room 3B01, Bethesda, MD 20892-7523, Email:

End Further Info End Preamble Start Supplemental Information


The conference is sponsored by the NIH Office of Dietary Supplements along with co-sponsors from 10 federal agencies. Information about the conference agenda, registration procedures, and webinar arrangements can be found at:​events/​Vitamin_​D_​Primary_​Care.

Through its Vitamin D Initiative, the National Institutes of Health (NIH) Office of Dietary Supplements (ODS) leads several efforts to advance scientific understanding of vitamin D and health:​Research/​VitaminD.aspx.

Start Signature

Dated: October 8, 2014.

Lawrence A. Tabak,

Principal Deputy Director, NIH.

End Signature End Supplemental Information

[FR Doc. 2014-24455 Filed 10-15-14; 8:45 am]